Jamie Mathew
About Jamie Mathew
Jamie Mathew is the Worldwide Medical Director for Cendakimab at Bristol Myers Squibb, with extensive experience in pediatric gastroenterology and a strong background in medical research.
Title
Jamie Mathew holds the title of Worldwide Medical Director, Cendakimab, at Bristol Myers Squibb. In this role, he guides the worldwide medical strategy for cendakimab, focusing on conditions such as eosinophilic esophagitis and atopic dermatitis.
Current Company
Jamie Mathew is currently employed at Bristol Myers Squibb, where he serves as the Worldwide Medical Director for Cendakimab. His role involves shaping the global medical direction for cendakimab, particularly in the treatment of eosinophilic esophagitis and atopic dermatitis.
Previous Experience at Children's Hospital at Montefiore
Jamie Mathew has accumulated substantial clinical experience at the Children's Hospital at Montefiore in Bronx, NY. He served as a Fellow in Pediatric Gastroenterology from 2018 to 2021 and as a Resident Physician from 2015 to 2018.
Educational Background
Jamie Mathew has an extensive educational background in various fields of medicine and science. He earned his MD from New York Medical College between 2011 and 2015 and also holds a Master of Science in Basic Medical Science from the same institution, achieved from 2009 to 2011. His foundational education includes a Bachelor of Arts in Psychology from the University of Pennsylvania, completed from 2004 to 2009.
Medical and Research Credentials
Board Certified in both Pediatrics and Pediatric Gastroenterology, Jamie Mathew combines clinical and research expertise. His past roles include a three-year tenure as a Research Assistant in the Department of Physiology at New York Medical College. This experience aids in his integrated approach to developing medical strategies.